Modulation of neural stem cells by use of EGFL7 or EGFL7 antagonists
Scientists from the university hospital of Frankfurt am Main prove for the first time, that the signalling protein EGFL7 binds to notch receptors and regulates the self renewal of neural stem cells. Therefore, EGFL7, EGFL7 antagonists and EGFL7 antibodies can be used to grow specialised cells and tissues from neural stem cells and to treat lesions and neurodegenerative diseases of the central nervous system.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Combining robotics and ChatGPT
TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…
How the Immune System Learns from Harmless Particles
Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…
Biomarkers identified for successful treatment of bone marrow tumours
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…
